Search

Your search keyword '"Purpura, Thrombocytopenic, Idiopathic surgery"' showing total 61 results

Search Constraints

Start Over You searched for: Descriptor "Purpura, Thrombocytopenic, Idiopathic surgery" Remove constraint Descriptor: "Purpura, Thrombocytopenic, Idiopathic surgery" Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
61 results on '"Purpura, Thrombocytopenic, Idiopathic surgery"'

Search Results

1. Proteomics landscape and machine learning prediction of long-term response to splenectomy in primary immune thrombocytopenia.

2. Study of platelet kinetics in immune thrombocytopenia to predict splenectomy response.

3. Is splenectomy a good strategy for refractory immune thrombocytopenia in adults?

4. Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopenia.

5. Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment.

6. Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years.

7. A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia.

8. Autologous 111 In-labelled platelet scan as a predictor of splenectomy outcome in ITP.

9. Systematic literature review of treatments used for adult immune thrombocytopenia in the second-line setting.

10. Systematic detection of portal or splenic vein thrombosis after splenectomy for immune cytopenia.

11. A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.

12. Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.

13. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.

14. Mycophenolate mofetil therapy for severe immune thrombocytopenia.

15. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.

16. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.

17. The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study.

18. Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.

19. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy.

20. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.

21. Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.

22. Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis.

23. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.

24. Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents.

26. Non-vitrectomizing vitreous surgery for premacular haemorrhage.

27. Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry.

28. Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic review.

29. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.

32. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial.

33. Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept.

35. Splenectomy for immune thrombocytopenic purpura: surgery for the 21st century.

36. Concurrent immune thrombocytopenic purpura and Guillain-Barre syndrome in a patient with Hashimoto's thyroiditis.

37. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.

38. Analysis of outcome of laparoscopic splenectomy for idiopathic thrombocytopenic purpura by platelet count.

39. Thromboembolic complications after splenectomy for hematologic diseases.

40. Retrospective evaluation of long-term efficacy and safety of splenectomy in chronic idiopathic thrombocytopenic purpura in children.

42. Splenunculectomy in autoimmune thrombocytopenic purpura.

43. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care.

44. Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis.

45. Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy.

46. Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma.

47. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?

48. Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura.

49. Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients.

50. Th1 and Th2 cytokines in a patient with Evans' syndrome and profound lymphopenia.

Catalog

Books, media, physical & digital resources